Shigeo Fuji

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Venues

Bone marrow transplantation

Expert review of anti-infective therapy

Annals of hematology

International journal of hematology

Osaka International Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka International Cancer Institute Apr 01 2017

Japan

Director :: Hematology

Publications

Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy (2024)
Akihiro Ohmoto, Shigeo Fuji
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert review of anti-infective therapy 22 (4) (2024)
Akihiro Ohmoto, Shigeo Fuji
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert review of anti-infective therapy (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Akihiro Ohmoto, Shigeo Fuji
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert review of anti-infective therapy 22 (4) (2024)
Toshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, Shunto Kawamura, Takashi Toya, Kazuteru Ohashi, Naoyuki Uchida, Masatsugu Tanaka, Takahiro Fukuda, Masashi Sawa, Jun Ishikawa, Tetsuya Nishida, Hiroyuki Ohigashi, Yumiko Maruyama, Shin-Ichiro Fujiwara, Yoshinobu Kanda, Shuichi Ota, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Masao Ogata, Kimikazu Yakushijin, Hideaki Nakasone
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era. Bone marrow transplantation (2024)
Akihiro Ohmoto, Shigeo Fuji
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert review of anti-infective therapy (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Toshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, Shunto Kawamura, Takashi Toya, Kazuteru Ohashi, Naoyuki Uchida, Masatsugu Tanaka, Takahiro Fukuda, Masashi Sawa, Jun Ishikawa, Tetsuya Nishida, Hiroyuki Ohigashi, Yumiko Maruyama, Shin-Ichiro Fujiwara, Yoshinobu Kanda, Shuichi Ota, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Masao Ogata, Kimikazu Yakushijin, Hideaki Nakasone
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era. Bone marrow transplantation 59 (9) (2024)
Shigeo Fuji, Hirohisa Nakamae, Junichi Sugita, Yuho Najima, Tatsuya Konishi, Takashi Tanaka, Yasuhiro Nakashima, Mitsutaka Nishimoto, Hiroshi Okamura, Kazutaka Nakayama, Ayumu Ito, Makoto Yoshimitsu, Masayuki Hino, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin
Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation. Bone marrow transplantation (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy 22 (5) (2024)
Akihiro Ohmoto, Shigeo Fuji
Non-cancerous complications in HTLV-1 carriers. Expert review of anti-infective therapy (2024)
Akihiro Ohmoto, Shigeo Fuji
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice. Expert review of anti-infective therapy 22 (4) (2024)
Shigeo Fuji, Junichi Sugita, Yuho Najima, Tatsuya Konishi, Takashi Tanaka, Hiroyuki Ohigashi, Tetsuya Eto, Koji Nagafuji, Nobuhiro Hiramoto, Ken-Ichi Matsuoka, Yumiko Maruyama, Shuichi Ota, Jun Ishikawa, Toshiro Kawakita, Takashi Akasaka, Tomohiko Kamimura, Masayuki Hino, Takahiro Fukuda, Yoshiko Atsuta, Kimikazu Yakushijin
Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation. British journal of haematology (2023)
Shigeo Fuji, Reiko Sakai
Apoptotic abnormal lymphocytes as a possible early indicator of clinical response in patients with ATL. EJHaem 5 (1) (2023)
Shigeo Fuji, Yoshitaka Inoue, Junya Makiyama, Nobuaki Nakano, Ayumu Ito, Toshiro Kawakita, Tetsuya Eto, Youko Suehiro, Hidehiro Itonaga, Yasushi Sawayama, Yasuo Mori, Naoyuki Uchida, Satoko Morishima, Makoto Onizuka, Kenji Ishitsuka, Takahiro Fukuda, Yoshiko Atsuta, Makoto Yoshimitsu
The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy. Bone marrow transplantation (2023)
Makiko Suga, Shigeo Fuji, Yuma Tada, Kazuhito Tsutsumi, Shuhei Kida, Kumi Shibata, Ryo Nakata, Yasuhiro Shingai, Sayako Yuda, Takafumi Yokota, Jun Ishikawa
A single-institution pre-post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients. British journal of haematology (2023)
Takashi Mizuoka, Hiroyuki Sakamaki, Shigeo Fuji, Shota Saito, Tatsunori Murata, Shinya Ohno, Naoki Inubashiri, Tomoha Oshima, Kazuhito Yamamoto
Cost-effectiveness of combination therapy of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone for previously untreated diffuse large B-cell lymphoma in Japan. Journal of medical economics (2023)
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Takahiro Fukuda, Noriko Doki, Yuta Katayama, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Masatsugu Tanaka, Keisuke Kataoka, Takahide Ara, Masashi Sawa, Makoto Onizuka, Yasushi Onishi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy. Bone marrow transplantation (2023)
Shigeo Fuji, Reiko Sakai
Apoptotic abnormal lymphocytes as a possible early indicator of clinical response in patients with ATL. EJHaem 5 (1) (2023)
Akihiro Ohmoto, Shigeo Fuji
Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen. Expert review of hematology (2023)
Shigeo Fuji, Sayako Yuda, Yuma Tada, Mitsuki Kano, Kazuhiro Sanda, Keigo Fujishita, Takuya Terakawa, Yasuhiro Shingai, Hidenori Kasahara, Takafumi Yokota, Jun Ishikawa
A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL. British journal of haematology (2023)
Shigeo Fuji, Masakazu Muta, Eiichiro Ikeda, Reiko Sakai, Yuuji Hagiwara, Kazuki Zaizen, Junya Makiyama, Ilseung Choi, Kuniko Takano, Ki-Ryang Koh, Jun Ishikawa
Discordance in the morphologic diagnosis of lymphocytes in HTLV-1-infected individuals. International journal of laboratory hematology 44 (5) (2022)
Shigeo Fuji, Tsuneaki Hirakawa, Kuniko Takano, Kazuteru Ohashi, Masashi Sawa, Yoshinobu Kanda, Naoyuki Uchida, Takahide Ara, Toshihiro Miyamoto, Tetsuya Eto, Ken-Ichi Matsuoka, Toshiro Kawakita, Yukiyasu Ozawa, Yuta Katayama, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Hideki Nakasone
Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group. Bone marrow transplantation 57 (3) (2022)
Sayako Yuda, Shigeo Fuji, Bipin Savani, Katie S Gatwood
Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation. Clinical hematology international 4 (3) (2022)
Akihiro Ohmoto, Shigeo Fuji, Kendall C Shultes, Bipin N Savani, Hermann Einsele
Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia. Bone marrow transplantation 57 (6) (2022)
Akio Onishi, Shigeo Fuji, Shigehisa Kitano, Akiko Miyagi Maeshima, Kinuko Tajima, Junko Yamaguchi, Ichiro Kawashima, Akihisa Kawajiri, Tomonari Takemura, Ayumu Ito, Takashi Tanaka, Keiji Okinaka, Yoshihiro Inamoto, Saiko Kurosawa, Sung-Won Kim, Wataru Munakata, Dai Maruyama, Kensei Tobinai, Takahiro Fukuda
Prognostic implication of CTLA-4, PD-1, and PD-L1 expression in aggressive adult T-cell leukemia-lymphoma. Annals of hematology 101 (4) (2022)
Yoshitaka Inoue, Nobuaki Nakano, Shigeo Fuji, Tetsuya Eto, Toshiro Kawakita, Youko Suehiro, Toshihiro Miyamoto, Yasushi Sawayama, Naoyuki Uchida, Tadakazu Kondo, Junya Kanda, Yoshiko Atsuta, Takahiro Fukuda, Makoto Yoshimitsu, Koji Kato, null null
Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma. Bone marrow transplantation 56 (12) (2021)
Akihiro Ohmoto, Shigeo Fuji
Cardiac complications associated with hematopoietic stem-cell transplantation. Bone marrow transplantation 56 (11) (2021)
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Makoto Murata, Seitaro Terakura, Yoshihiro Inamoto, Naoyuki Uchida, Takashi Toya, Tetsuya Eto, Hirohisa Nakamae, Kazuhiro Ikegame, Masatsugu Tanaka, Toshiro Kawakita, Tadakazu Kondo, Toshihiro Miyamoto, Takahiro Fukuda, Tatsuo Ichinohe, Takafumi Kimura, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Impact of HLA disparity on the risk of overall mortality in patients with grade II-IV acute GVHD on behalf of the HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation 56 (12) (2021)
Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa
Long-term trends in the clinical outcomes of patients with acute myeloid leukemia: a population-based real-world data analysis using the Osaka Cancer Registry. Annals of hematology 100 (11) (2021)
Shuhei Kida, Shigeo Fuji, Toshitaka Morishima, Kayo Nakata, Isao Miyashiro, Jun Ishikawa
Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry. International journal of hematology 114 (2) (2021)
Shigeo Fuji, Michael Byrne, Arnon Nagler, Mohamad Mohty, Bipin N Savani
How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (6) (2021)
Ayumu Ito, Nobuaki Nakano, Takashi Tanaka, Shigeo Fuji, Junya Makiyama, Yoshitaka Inoue, Ilseung Choi, Hirohisa Nakamae, Koji Nagafuji, Ken Takase, Shinichiro Machida, Tsutomu Takahashi, Yasushi Sawayama, Tomohiko Kamimura, Koji Kato, Toshiro Kawakita, Masao Ogata, Rika Sakai, Souichi Shiratori, Kaoru Uchimaru, Yoshihiro Inamoto, Atae Utsunomiya, Takahiro Fukuda
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study. Blood advances 5 (20) (2021)
Shigeo Fuji, Yuma Tada, Kenji Nozaki, Hideaki Saito, Takayuki Ozawa, Toru Kida, Satoru Kosugi, Hiroyuki Sugahara, Hirokazu Ikeda, Koji Hashimoto, Takahiro Karasuno, Shuji Ueda, Jun Ishikawa, Hirohiko Shibayama
A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy. Annals of hematology 99 (9) (2020)
Shigeo Fuji, Arnon Nagler, Mohamad Mohty, Bipin P Savani, Roni Shouval
Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy. Bone marrow transplantation 55 (7) (2020)
Akio Onishi, Yoshihiro Inamoto, Kinuko Tajima, Junko Yamaguchi, Ichiro Kawashima, Akihisa Kawajiri, Tomonari Takemura, Ayumu Ito, Takashi Tanaka, Keiji Okinaka, Shigeo Fuji, Saiko Kurosawa, Sung-Won Kim, Takahiro Fukuda
Detrimental effects of pretransplant cisplatin-based chemotherapy on renal function after allogeneic hematopoietic cell transplantation for lymphoma. Bone marrow transplantation 55 (11) (2020)
Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa
Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry. Annals of hematology 100 (1) (2020)
Shigeo Fuji, Shuhei Kida, Kayo Nakata, Toshitaka Morishima, Isao Miyashiro, Jun Ishikawa
Analysis of real-world data in patients with relapsed/refractory diffuse large B cell lymphoma who received salvage chemotherapy in the rituximab era. Annals of hematology 100 (9) (2020)
Motohiro Kato, Hideki Nakasone, Nobuaki Nakano, Shigeo Fuji, Akihito Shinohara, Hisayuki Yokoyama, Kazuo Sakashita, Tsukasa Hori, Satoshi Takahashi, Miho Nara, Yoshinobu Kanda, Takehiko Mori, Junko Takita, Hiroshi Kawaguchi, Toshiro Kawakita, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Masao Ogata, null null
Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 55 (6) (2019)
Shigeo Fuji, Saiko Kurosawa, Yoshihiro Inamoto, Tatsunori Murata, Atae Utsunomiya, Kaoru Uchimaru, Satoshi Yamasaki, Yoshitaka Inoue, Yukiyoshi Moriuchi, Ilseung Choi, Masao Ogata, Michihiro Hidaka, Takuhiro Yamaguchi, Takahiro Fukuda
A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma. International journal of hematology 111 (3) (2019)
Shigeo Fuji, Kumi Oshima, Kazuteru Ohashi, Masashi Sawa, Takeshi Saito, Tetsuya Eto, Masatsugu Tanaka, Makoto Onizuka, Hirohisa Nakamae, Souichi Shiratori, Yukiyasu Ozawa, Michihiro Hidaka, Tokiko Nagamura-Inoue, Hidenori Tanaka, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Masao Ogata
Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone marrow transplantation 55 (4) (2019)
Shigeo Fuji, Yuma Tada, Ryo Nakata, Keiichi Nakata, Midori Koike, Shuhei Kida, Kazuhito Tsutsumi, Hiroaki Masaie, Hitoshi Yoshida, Jun Ishikawa
GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience. International journal of hematology 111 (2) (2019)
Shigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, Atae Utsunomiya, Yukiyoshi Moriuchi, Satsuki Owatari, Takashi Miyagi, Yasushi Sawayama, Eiichi Otsuka, Shin-Ichiro Yoshida, Takahiro Fukuda
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis. Bone marrow transplantation 54 (9) (2019)
Shigeo Fuji, Koichi Miyamura, Yoshinobu Kanda, Takahiro Fukuda, Takeshi Kobayashi, Yukiyasu Ozawa, Koji Iwato, Naoyuki Uchida, Tetsuya Eto, Takashi Ashida, Takehiko Mori, Masashi Sawa, Tatsuo Ichinohe, Yoshiko Atsuta, Junya Kanda, null null
Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT. International journal of hematology 109 (6) (2019)
Makoto Yoshimitsu, Atae Utsunomiya, Shigeo Fuji, Hiroshi Fujiwara, Takahiro Fukuda, Hiroyasu Ogawa, Yoshifusa Takatsuka, Kenji Ishitsuka, Akira Yokota, Hirokazu Okumura, Kazuyoshi Ishii, Akinori Nishikawa, Tetsuya Eto, Akihito Yonezawa, Kaname Miyashita, Junichi Tsukada, Junji Tanaka, Yoshiko Atsuta, Koji Kato, null null
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphoma. Bone marrow transplantation 54 (8) (2018)

Shigeo Fuji.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shigeo Fuji